Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01950494 · ClinicalTrials.gov registry record · NA
FiteBac Hand Sanitizer in the Management of Hand Dermatitis in Adults
A NA study of Hand Dermatitis, sponsored by National Jewish Health.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
- 1
- Study location
NCT01950494 is a NA study of Hand Dermatitis that has completed, run by National Jewish Health. The registered enrollment target is 22 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01950494, a NA study of Hand Dermatitis, has completed, sponsored by National Jewish Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
Hand dermatitis, (a rash, or eczema, on the hands) is a common skin condition that affects approximately 10% of the population. It can be caused by a wide variety of things, such as allergens or irritants. For some, it can be painful and disfiguring. In moderate to severe cases, hand dermatitis can interfere greatly in the quality of life of the affected person, interfering with work and social functions. This can have a negative psychological effect as well. FiteBac Skin Care Gel is a new over-the-counter hand sanitizer that has been used for hospital and dental hand infection control. This product contains a germicide, to prevent infection. It also contains a silicone polymer. This makes the hand gel more durable, causing it to remain on the skin longer. Despite this durability, the hand gel still allows the skin to naturally perspire (sweat). As people in the health-care industry have used this new product with the goal of reducing hand infections, it has been noted that FiteBac Skin Care Gel also seems to have reduced hand dermatitis and improved personal skin condition. The purpose of this study is to scientifically measure skin improvement in a population of study subjects with hand dermatitis.
Conditions Studied
Interventions
- OTHER fiteBac Hand Sanitizer
Study Locations (1)
Colorado
- National Jewish Health - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2013-09 |
| Est. Completion | 2014-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01950494
The ClinicalTrials.gov registry entry for NCT01950494 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Jewish Health, which has 83 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hand Dermatitis appearing as the primary indexed condition, and to 1 intervention - of which fiteBac Hand Sanitizer is the first listed.
NCT01950494 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT01950494 about?
NCT01950494 is a clinical study titled "FiteBac Hand Sanitizer in the Management of Hand Dermatitis in Adults". Hand dermatitis, (a rash, or eczema, on the hands) is a common skin condition that affects approximately 10% of the population. It can be caused by a wide variety of things, such as allergens or irritants. For some, it can be painful and disfiguring. In moderate to severe cases, hand dermatitis can ...
What is the current status of trial NCT01950494?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2013-09. Estimated completion is 2014-07.
What conditions does trial NCT01950494 study?
This clinical trial studies the following conditions: Hand Dermatitis.
What interventions are being tested in trial NCT01950494?
The interventions under investigation include: fiteBac Hand Sanitizer (OTHER).
Who is sponsoring clinical trial NCT01950494?
This trial is sponsored by National Jewish Health, which has 83 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01950494 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.